Ullrich, Axel Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;
Ho, H. K., Nemeth, G., Ng, Y. R., Pang, E., Szantai-Kis, C., Zsakai, L., et al. (2013). Developing FGFR4 Inhibitors As Potential Anti-Cancer Agents Via In Silico Design, Supported by In Vitro and Cell-Based Testing. CURRENT MEDICINAL CHEMISTRY, 20(10), 1203-1217.